Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Breast Cancer

  Free Subscription


16.07.2018

1 Ann Oncol
9 Ann Surg Oncol
5 BMC Cancer
1 BMJ
2 Br J Cancer
1 Breast Cancer
1 Breast Cancer (Auckl)
3 Breast Cancer Res
3 Breast Cancer Res Treat
1 Breast J
2 Cancer Epidemiol Biomarkers Prev
1 Cancer Lett
2 Carcinogenesis
1 Clin Breast Cancer
4 Eur J Surg Oncol
1 Exp Cell Res
1 Gene
1 Histopathology
9 Int J Cancer
1 J Clin Oncol
1 J Natl Cancer Inst
2 JAMA
1 N Engl J Med
3 NPJ Breast Cancer
4 Oncogene
1 Oncol Rep
6 PLoS One
1 Proc Natl Acad Sci U S A
1 Radiother Oncol


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Ann Oncol

  1. ROBSON M
    Selecting patients with triple negative breast cancer for platinum-based therapy: we still haven't found what we're looking for.
    Ann Oncol. 2018 Jul 4. pii: 5048958. doi: 10.1093.
    PubMed     Text format    


    Ann Surg Oncol

  2. KILGORE LJ, Korentager SS, Hangge AN, Amin AL, et al
    Reducing Breast Cancer-Related Lymphedema (BCRL) Through Prospective Surveillance Monitoring Using Bioimpedance Spectroscopy (BIS) and Patient Directed Self-Interventions.
    Ann Surg Oncol. 2018 Jul 9. pii: 10.1245/s10434-018-6601.
    PubMed     Text format     Abstract available

  3. PARK TS, Thomas SM, Rosenberger LH, Fayanju OM, et al
    The Association of Extent of Axillary Surgery and Survival in Women with N2-3 Invasive Breast Cancer.
    Ann Surg Oncol. 2018 Jul 5. pii: 10.1245/s10434-018-6587.
    PubMed     Text format     Abstract available

  4. NGUYEN TT, Hoskin TL, Day CN, Degnim AC, et al
    Decreasing Use of Axillary Dissection in Node-Positive Breast Cancer Patients Treated with Neoadjuvant Chemotherapy.
    Ann Surg Oncol. 2018 Jul 5. pii: 10.1245/s10434-018-6637.
    PubMed     Text format     Abstract available

  5. SHIMAZU K, Sato N, Ogiya A, Sota Y, et al
    Intraoperative Nomograms, Based on One-Step Nucleic Acid Amplification, for Prediction of Non-sentinel Node Metastasis and Four or More Axillary Node Metastases in Breast Cancer Patients with Sentinel Node Metastasis.
    Ann Surg Oncol. 2018 Jul 5. pii: 10.1245/s10434-018-6633.
    PubMed     Text format     Abstract available

  6. DE LA CRUZ LM, Harhay MO, Zhang P, Ugras S, et al
    Impact of Neoadjuvant Chemotherapy on Breast Cancer Subtype: Does Subtype Change and, if so, How? : IHC Profile and Neoadjuvant Chemotherapy.
    Ann Surg Oncol. 2018 Jul 6. pii: 10.1245/s10434-018-6608.
    PubMed     Text format     Abstract available

  7. SCHWARTZBERG B, Lewin J, Abdelatif O, Bernard J, et al
    Phase 2 Open-Label Trial Investigating Percutaneous Laser Ablation for Treatment of Early-Stage Breast Cancer: MRI, Pathology, and Outcome Correlations.
    Ann Surg Oncol. 2018 Jul 9. pii: 10.1245/s10434-018-6623.
    PubMed     Text format     Abstract available

  8. ROSENKRANZ KM, Ballman K, McCall L, Kubicky C, et al
    The Feasibility of Breast-Conserving Surgery for Multiple Ipsilateral Breast Cancer: An Initial Report from ACOSOG Z11102 (Alliance) Trial.
    Ann Surg Oncol. 2018 Jul 9. pii: 10.1245/s10434-018-6583.
    PubMed     Text format     Abstract available

  9. WU SP, Tam M, Shaikh F, Lee A, et al
    Post-mastectomy Radiation Therapy in Breast Cancer Patients with Nodal Micrometastases.
    Ann Surg Oncol. 2018 Jul 9. pii: 10.1245/s10434-018-6632.
    PubMed     Text format     Abstract available

  10. AHN S, Wooster M, Valente C, Moshier E, et al
    Impact of Screening Mammography on Treatment in Women Diagnosed with Breast Cancer.
    Ann Surg Oncol. 2018 Jul 9. pii: 10.1245/s10434-018-6646.
    PubMed     Text format     Abstract available


    BMC Cancer

  11. LAMBERT LK, Balneaves LG, Howard AF, Chia SK, et al
    Understanding adjuvant endocrine therapy persistence in breast Cancer survivors.
    BMC Cancer. 2018;18:732.
    PubMed     Text format     Abstract available

  12. SLAOUI M, Zoure AA, Mouh FZ, Bensouda Y, et al
    Outcome of inflammatory breast cancer in Moroccan patients: clinical, molecular and pathological characteristics of 219 cases from the National Oncology Institute (INO).
    BMC Cancer. 2018;18:713.
    PubMed     Text format     Abstract available

  13. YOON YN, Choe MH, Jung KY, Hwang SG, et al
    MASTL inhibition promotes mitotic catastrophe through PP2A activation to inhibit cancer growth and radioresistance in breast cancer cells.
    BMC Cancer. 2018;18:716.
    PubMed     Text format     Abstract available

  14. HE Y, Tan EH, Wong ALA, Tan CC, et al
    Improving medication adherence with adjuvant aromatase inhibitor in women with breast cancer: study protocol of a randomised controlled trial to evaluate the effect of short message service (SMS) reminder.
    BMC Cancer. 2018;18:727.
    PubMed     Text format     Abstract available

  15. NUSHTAEVA AA, Stepanov GA, Semenov DV, Juravlev ES, et al
    Characterization of primary normal and malignant breast cancer cell and their response to chemotherapy and immunostimulatory agents.
    BMC Cancer. 2018;18:728.
    PubMed     Text format     Abstract available


    BMJ

  16. POTTER S, MacKenzie M, Blazeby JM
    Does the addition of mesh improve outcomes in implant based breast reconstruction after mastectomy for breast cancer?
    BMJ. 2018;362:k2607.
    PubMed     Text format    


    Br J Cancer

  17. STERLE HA, Nicoud MB, Massari NA, Taquez Delgado MA, et al
    Immunomodulatory role of histamine H4 receptor in breast cancer.
    Br J Cancer. 2018 Jul 10. pii: 10.1038/s41416-018-0173.
    PubMed     Text format     Abstract available

  18. LAMMERS PE, Dank M, Masetti R, Abbas R, et al
    Neoadjuvant PF-05280014 (a potential trastuzumab biosimilar) versus trastuzumab for operable HER2+ breast cancer.
    Br J Cancer. 2018 Jul 13. pii: 10.1038/s41416-018-0147.
    PubMed     Text format     Abstract available


    Breast Cancer

  19. OKUMATSU K, Tsujimoto T, Wakaba K, Seki A, et al
    Effects of a combined exercise plus diet program on cardiorespiratory fitness of breast cancer patients.
    Breast Cancer. 2018 Jul 10. pii: 10.1007/s12282-018-0889.
    PubMed     Text format     Abstract available


    Breast Cancer (Auckl)

  20. SALINAS JJ, Byrd T, Martin C, Dwivedi AK, et al
    Change in Breast Cancer Screening Knowledge is Associated With Change in Mammogram Intention in Mexican-Origin Women After an Educational Intervention.
    Breast Cancer (Auckl). 2018;12:1178223418782904.
    PubMed     Text format     Abstract available


    Breast Cancer Res

  21. SHAPIRA M, Kakiashvili E, Rosenberg T, Hershko DD, et al
    Correction to: The mTOR inhibitor rapamycin down-regulates the expression of the ubiquitin ligase subunit Skp2 in breast cancer cells.
    Breast Cancer Res. 2018;20:68.
    PubMed     Text format     Abstract available

  22. O'BRIEN KM, Sandler DP, Xu Z, Kinyamu HK, et al
    Vitamin D, DNA methylation, and breast cancer.
    Breast Cancer Res. 2018;20:70.
    PubMed     Text format     Abstract available

  23. PAPADAKI C, Stratigos M, Markakis G, Spiliotaki M, et al
    Circulating microRNAs in the early prediction of disease recurrence in primary breast cancer.
    Breast Cancer Res. 2018;20:72.
    PubMed     Text format     Abstract available


    Breast Cancer Res Treat

  24. SAHA A, Harowicz MR, Cain EH, Hall AH, et al
    Intra-tumor molecular heterogeneity in breast cancer: definitions of measures and association with distant recurrence-free survival.
    Breast Cancer Res Treat. 2018 Jul 10. pii: 10.1007/s10549-018-4879.
    PubMed     Text format     Abstract available

  25. REDITI M, Messina C
    Towards treatment personalisation in triple negative breast cancer: role of platinum-based neoadjuvant chemotherapy.
    Breast Cancer Res Treat. 2018 Jul 12. pii: 10.1007/s10549-018-4885.
    PubMed     Text format    

  26. BANYS-PALUCHOWSKI M, Witzel I, Riethdorf S, Pantel K, et al
    The clinical relevance of serum vascular endothelial growth factor (VEGF) in correlation to circulating tumor cells and other serum biomarkers in patients with metastatic breast cancer.
    Breast Cancer Res Treat. 2018 Jul 12. pii: 10.1007/s10549-018-4882.
    PubMed     Text format     Abstract available


    Breast J

  27. AZIM HA, Lasheen S, Kassem L
    Treatment of HER2-positive early breast cancer: How to best balance efficacy and toxicity?
    Breast J. 2018;24:459-461.
    PubMed     Text format    


    Cancer Epidemiol Biomarkers Prev

  28. BOYNE DJ, O'Sullivan DE, Olij BF, King WD, et al
    Physical Activity, Global DNA Methylation and Breast Cancer Risk: A Systematic Literature Review and Meta-Analysis.
    Cancer Epidemiol Biomarkers Prev. 2018 Jul 10. pii: 1055-9965.EPI-18-0175.
    PubMed     Text format     Abstract available

  29. BERGIN RJ, Emery J, Bollard RC, Falborg AZ, et al
    Rural-urban disparities in time to diagnosis and treatment for colorectal and breast cancer.
    Cancer Epidemiol Biomarkers Prev. 2018 Jul 9. pii: 1055-9965.EPI-18-0210.
    PubMed     Text format     Abstract available


    Cancer Lett

  30. LIU XL, Xu YC, Wang YX, Chen Y, et al
    Decrease in phosphorylated ERK indicates the therapeutic efficacy of a clinical PI3Kalpha-selective inhibitor CYH33 in breast cancer.
    Cancer Lett. 2018 Jul 9. pii: S0304-3835(18)30469.
    PubMed     Text format     Abstract available


    Carcinogenesis

  31. CHAI C, Wu H, Wang B, Eisenstat DD, et al
    MicroRNA-498 promotes proliferation and migration by targeting the tumor suppressor PTEN in breast cancer cells.
    Carcinogenesis. 2018 Jul 7. pii: 5050474. doi: 10.1093.
    PubMed     Text format     Abstract available

  32. KUMAR N, Prasad P, Jash E, Jayasundar S, et al
    cAMP Regulated EPAC1 Supports Microvascular Density, Angiogenic and Metastatic Properties in a Model of Triple Negative Breast Cancer.
    Carcinogenesis. 2018 Jul 5. pii: 5049417. doi: 10.1093.
    PubMed     Text format     Abstract available


    Clin Breast Cancer

  33. ZHU X, Huang JM, Zhang K, Xia LJ, et al
    Diagnostic Value of Contrast-Enhanced Spectral Mammography for Screening Breast Cancer: Systematic Review and Meta-analysis.
    Clin Breast Cancer. 2018 Jun 15. pii: S1526-8209(18)30008.
    PubMed     Text format     Abstract available


    Eur J Surg Oncol

  34. ROMICS L, Macaskill EJ, Fernandez T, Simpson L, et al
    A population-based audit of surgical practice and outcomes of oncoplastic breast conservations in Scotland - An analysis of 589 patients.
    Eur J Surg Oncol. 2018;44:939-944.
    PubMed     Text format     Abstract available

  35. TEMPFER CB, Hilal Z, Dogan A, Petersen M, et al
    Concentrations of cisplatin and doxorubicin in ascites and peritoneal tumor nodules before and after pressurized intraperitoneal aerosol chemotherapy (PIPAC) in patients with peritoneal metastasis.
    Eur J Surg Oncol. 2018;44:1112-1117.
    PubMed     Text format     Abstract available

  36. DE LORENZI F, Di Bella J, Maisonneuve P, Rotmensz N, et al
    Oncoplastic breast surgery for the management of ductal carcinoma in situ (DCIS): is it oncologically safe? A retrospective cohort analysis.
    Eur J Surg Oncol. 2018;44:957-962.
    PubMed     Text format     Abstract available

  37. NAZZANI S, Preisser F, Mazzone E, Tian Z, et al
    In-hospital length of stay after major surgical oncological procedures.
    Eur J Surg Oncol. 2018;44:969-974.
    PubMed     Text format     Abstract available


    Exp Cell Res

  38. CHEN JH, Kuo KT, Bamodu OA, Lin YC, et al
    Upregulated SCUBE2 expression in breast cancer stem cells enhances triple negative breast cancer aggression through modulation of notch signaling and epithelial-to-mesenchymal transition.
    Exp Cell Res. 2018 Jul 4. pii: S0014-4827(18)30398.
    PubMed     Text format     Abstract available


    Gene

  39. JIANG M, Xiao Y, Liu D, Luo N, et al
    Overexpression of long noncoding RNA LINC01296 indicates an unfavorable prognosis and promotes tumorigenesis in breast cancer.
    Gene. 2018 Jul 4. pii: S0378-1119(18)30773-X. doi: 10.1016/j.gene.2018.
    PubMed     Text format     Abstract available


    Histopathology

  40. RAKHA EA, Aleskandarany MA, Toss MS, Mongan N, et al
    Impact of Breast Cancer Grade Discordance on Prediction of Outcome.
    Histopathology. 2018 Jul 12. doi: 10.1111/his.13709.
    PubMed     Text format     Abstract available


    Int J Cancer

  41. BLUMENFELD Z
    Anti-Mullerian hormone and breast cancer risk- is the correlation possibly associated with the PCOS?
    Int J Cancer. 2018 Jul 10. doi: 10.1002/ijc.31732.
    PubMed     Text format    

  42. PARK YH, Lee KH, Sohn JH, Lee KS, et al
    A phase II trial of the pan-HER inhibitor poziotinib, in patients with HER2-positive metastatic breast cancer who had received at least two prior HER2-directed regimens: results of the NOV120101-203 trial.
    Int J Cancer. 2018 Jul 6. doi: 10.1002/ijc.31651.
    PubMed     Text format     Abstract available

  43. SALEM Y, Yacov N, Propheta-Meiran O, Breitbart E, et al
    Newly Characterized Motile Sperm Domain-Containing Protein 2 Promotes Human Breast Cancer Metastasis.
    Int J Cancer. 2018 Jul 6. doi: 10.1002/ijc.31665.
    PubMed     Text format     Abstract available

  44. LAN B, Ma F, Chen S, Wang W, et al
    Toremifene, rather than tamoxifen, might be a better option for the adjuvant endocrine therapy in CYP2D6*10 T/T genotype breast cancer patients in China.
    Int J Cancer. 2018 Jul 6. doi: 10.1002/ijc.31639.
    PubMed     Text format     Abstract available

  45. FARVID MS, Chen WY, Rosner BA, Tamimi RM, et al
    Fruit and vegetable consumption and breast cancer incidence: Repeated measures over 30 years of follow-up.
    Int J Cancer. 2018 Jul 6. doi: 10.1002/ijc.31653.
    PubMed     Text format     Abstract available

  46. MCCORMACK V, Febvey-Combes O, Ginsburg O, Dos-Santos-Silva I, et al
    Breast cancer in women living with HIV: A first global estimate.
    Int J Cancer. 2018 Jul 11. doi: 10.1002/ijc.31722.
    PubMed     Text format     Abstract available

  47. TESCH H, Stoetzer O, Decker T, Kurbacher CM, et al
    Efficacy and safety of everolimus plus exemestane in postmenopausal women with hormone receptor-positive, human epidermal growth factor receptor 2-negative locally advanced or metastatic breast cancer: Results of the single-arm, phase IIIB 4EVER trial
    Int J Cancer. 2018 Jul 11. doi: 10.1002/ijc.31738.
    PubMed     Text format     Abstract available

  48. CLENDENEN TV, Dorgan J, Zeleniuch-Jacquotte A
    Reply to: Anti-Mullerian hormone and breast cancer risk- is the correlation possibly associated with the PCOS?
    Int J Cancer. 2018 Jul 11. doi: 10.1002/ijc.31728.
    PubMed     Text format    

  49. VANGANGELT KMH, Tollenaar LSA, van Pelt GW, de Kruijf EM, et al
    The prognostic value of tumor-stroma ratio in tumor-positive axillary lymph nodes of breast cancer patients.
    Int J Cancer. 2018 Jul 6. doi: 10.1002/ijc.31658.
    PubMed     Text format     Abstract available


    J Clin Oncol

  50. HU JJ, Urbanic JJ, Case LD, Takita C, et al
    Association Between Inflammatory Biomarker C-Reactive Protein and Radiotherapy-Induced Early Adverse Skin Reactions in a Multiracial/Ethnic Breast Cancer Population.
    J Clin Oncol. 2018 Jul 10:JCO2017771790. doi: 10.1200/JCO.2017.77.1790.
    PubMed     Text format     Abstract available


    J Natl Cancer Inst

  51. DAVIS LYNN BC, Rosenberg PS, Anderson WF, Gierach GL, et al
    Black-White Breast Cancer Incidence Trends: Effects of Ethnicity.
    J Natl Cancer Inst. 2018 Jul 5. pii: 5049141. doi: 10.1093.
    PubMed     Text format     Abstract available


    JAMA

  52. HERSHMAN DL, Unger JM, Greenlee H, Capodice JL, et al
    Effect of Acupuncture vs Sham Acupuncture or Waitlist Control on Joint Pain Related to Aromatase Inhibitors Among Women With Early-Stage Breast Cancer: A Randomized Clinical Trial.
    JAMA. 2018;320:167-176.
    PubMed     Text format     Abstract available

  53. ABBASI J
    Immunotherapy Leads to Complete Regression in Late-Stage Breast Cancer.
    JAMA. 2018;320:127.
    PubMed     Text format    


    N Engl J Med

  54. STEARNS V
    TAILORing Adjuvant Systemic Therapy for Breast Cancer.
    N Engl J Med. 2018;379:191-192.
    PubMed     Text format    


    NPJ Breast Cancer

  55. SZTUPINSZKI Z, Diossy M, Krzystanek M, Reiniger L, et al
    Migrating the SNP array-based homologous recombination deficiency measures to next generation sequencing data of breast cancer.
    NPJ Breast Cancer. 2018;4:16.
    PubMed     Text format     Abstract available

  56. BEVERLY CM, Naughton MJ, Pennell ML, Foraker RE, et al
    Change in longitudinal trends in sleep quality and duration following breast cancer diagnosis: results from the Women's Health Initiative.
    NPJ Breast Cancer. 2018;4:15.
    PubMed     Text format     Abstract available

  57. PETKOV VI, Miller DP, Howlader N, Gliner N, et al
    Erratum: Author Correction: Breast-cancer-specific mortality in patients treated based on the 21-gene assay: a SEER population-based study.
    NPJ Breast Cancer. 2018;4:17.
    PubMed     Text format     Abstract available


    Oncogene

  58. LUO L, Tang H, Ling L, Li N, et al
    LINC01638 lncRNA activates MTDH-Twist1 signaling by preventing SPOP-mediated c-Myc degradation in triple-negative breast cancer.
    Oncogene. 2018 Jul 12. pii: 10.1038/s41388-018-0396.
    PubMed     Text format     Abstract available

  59. YANG T, Ren C, Qiao P, Han X, et al
    PIM2-mediated phosphorylation of hexokinase 2 is critical for tumor growth and paclitaxel resistance in breast cancer.
    Oncogene. 2018 Jul 9. pii: 10.1038/s41388-018-0386.
    PubMed     Text format     Abstract available

  60. GUO X, Zhang Y, Mayakonda A, Madan V, et al
    ARID1A and CEBPalpha cooperatively inhibit UCA1 transcription in breast cancer.
    Oncogene. 2018 Jul 6. pii: 10.1038/s41388-018-0371.
    PubMed     Text format     Abstract available

  61. LI A, Chen P, Leng Y, Kang J, et al
    Histone deacetylase 6 regulates the immunosuppressive properties of cancer-associated fibroblasts in breast cancer through the STAT3-COX2-dependent pathway.
    Oncogene. 2018 Jul 6. pii: 10.1038/s41388-018-0379.
    PubMed     Text format     Abstract available


    Oncol Rep

  62. GUAN J, Zhou Y, Mao F, Lin Y, et al
    MicroRNA320a suppresses tumor cell growth and invasion of human breast cancer by targeting insulinlike growth factor 1 receptor.
    Oncol Rep. 2018;40:849-858.
    PubMed     Text format     Abstract available


    PLoS One

  63. PANNUTI A, Filipovic A, Hicks C, Lefkowitz E, et al
    Novel putative drivers revealed by targeted exome sequencing of advanced solid tumors.
    PLoS One. 2018;13:e0194790.
    PubMed     Text format     Abstract available

  64. CHOI SW, Ryu SY, Han MA, Park J, et al
    Higher breast cancer prevalence associated with higher socioeconomic status in the South Korean population; Has it resulted from overdiagnosis?
    PLoS One. 2018;13:e0200484.
    PubMed     Text format     Abstract available

  65. KIM YY, Oh SJ, Chun YS, Lee WK, et al
    Gene expression assay and Watson for Oncology for optimization of treatment in ER-positive, HER2-negative breast cancer.
    PLoS One. 2018;13:e0200100.
    PubMed     Text format     Abstract available

  66. TYURYUMINA EY, Neznanov AA
    Consolidated mathematical growth model of the primary tumor and secondary distant metastases of breast cancer (CoMPaS).
    PLoS One. 2018;13:e0200148.
    PubMed     Text format     Abstract available

  67. SUN X, Stewart DA, Sandhu R, Kirk EL, et al
    Correlated metabolomic, genomic, and histologic phenotypes in histologically normal breast tissue.
    PLoS One. 2018;13:e0193792.
    PubMed     Text format     Abstract available

  68. BINDER K, Krauss S, Bruckmaier G, Marienhagen J, et al
    Visualizing the Bayesian 2-test case: The effect of tree diagrams on medical decision making.
    PLoS One. 2018;13:e0195029.
    PubMed     Text format     Abstract available


    Proc Natl Acad Sci U S A

  69. XIAO T, Li W, Wang X, Xu H, et al
    Estrogen-regulated feedback loop limits the efficacy of estrogen receptor-targeted breast cancer therapy.
    Proc Natl Acad Sci U S A. 2018 Jul 9. pii: 1722617115.
    PubMed     Text format     Abstract available


    Radiother Oncol

  70. BROUWERS PJAM, van Werkhoven E, Bartelink H, Fourquet A, et al
    Predictors for poor cosmetic outcome in patients with early stage breast cancer treated with breast conserving therapy: Results of the Young boost trial.
    Radiother Oncol. 2018 Jul 3. pii: S0167-8140(18)33335.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Breast Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: